AMPH (STOCKS)
Amphastar Pharmaceuticals, Inc.
$19.710000
-0.380000 (-1.89%)
Prev close: $20.090000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Yong Feng Zhang
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $868.63M
- Employees
- 2,028
- P/E (TTM)
- 12.07
- P/B (TTM)
- 1.16
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
9
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.42 | $0.72 | -0.2991 | -41.59% |
|
Dec 2025 (Q4)
|
$0.73 | $0.94 | -0.2107 | -22.40% |
|
Sep 2025 (Q3)
|
$0.93 | $0.84 | +0.0890 | +10.58% |
|
Jun 2025 (Q2)
|
$0.85 | $0.76 | +0.0942 | +12.46% |
Financial Statements
| Revenues | $720.53M |
| Benefits Costs and Expenses | $617.72M |
| Cost Of Revenue | $379.40M |
| Costs And Expenses | $617.72M |
| Gross Profit | $341.13M |
| Nonoperating Income/Loss | -$13.93M |
| Operating Expenses | $224.39M |
| Research and Development | $92.49M |
| Other Operating Expenses | $131.90M |
| Operating Income/Loss | $116.74M |
| Income/Loss From Continuing Operations After Tax | $79.23M |
| Income/Loss From Continuing Operations Before Tax | $102.81M |
| Income Tax Expense/Benefit | $23.59M |
| Net Income/Loss | $79.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $79.23M |
| Net Income/Loss Available To Common Stockholders, Basic | $79.23M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.71 |
| Diluted Earnings Per Share | $1.66 |
| Basic Average Shares | 138,467,000 |
| Diluted Average Shares | 141,913,000 |
| Assets | $1.65B |
| Current Assets | $633.68M |
| Inventory | $170.19M |
| Other Current Assets | $463.49M |
| Noncurrent Assets | $1.01B |
| Fixed Assets | $307.23M |
| Other Non-current Assets | $707.25M |
| Liabilities | $874.77M |
| Current Liabilities | $164.48M |
| Accounts Payable | $35.50M |
| Wages | $30.57M |
| Other Current Liabilities | $98.41M |
| Noncurrent Liabilities | $710.29M |
| Equity | $773.39M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $773.39M |
| Liabilities And Equity | $1.65B |
| Net Cash Flow From Operating Activities | $168.88M |
| Net Cash Flow From Operating Activities, Continuing | $168.88M |
| Net Cash Flow From Investing Activities | -$97.55M |
| Net Cash Flow From Investing Activities, Continuing | -$97.55M |
| Net Cash Flow From Financing Activities | -$83.13M |
| Net Cash Flow From Financing Activities, Continuing | -$83.13M |
| Exchange Gains/Losses | -$46.00K |
| Net Cash Flow | -$11.84M |
| Net Cash Flow, Continuing | -$11.80M |
| Comprehensive Income/Loss | $78.85M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $81.46M |
| Other Comprehensive Income/Loss | $16.98M |
| Other Comprehensive Income/Loss Attributable To Parent | $2.23M |